PAIN TRIGGERS
Experiencing severe negative side effects and overstimulation from stimulant medications.
SaaS· individuals diagnosed with ADHDPain 8.00/10WTP 6.0/10Market 7.0/10Validation 9.0Confidence 95%Aug 9, 2026
TitrateTrack: Structured Symptom & Dosages Log for ADHD Medication Titration
Standard ADHD stimulant titration often leads to severe side effects like overstimulation, anxiety, and high blood pressure, leaving patients without a structured way to track metrics or communicate effectively with their prescribers.
healthcaremental-healthmobile-apppatientsproductivitysaastrackingwellness
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
Difficulty finding the right ADHD medication and dosage without experiencing severe side effects like overstimulation, high blood pressure, anxiety, paranoia, and derealisation.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
Need advice - switch back to concerta? Or try lower vyvanse dosage?
ADHD26
Need advice - switch back to concerta? Or try lower vyvanse dosage?
ADHD26
Need advice - switch back to concerta? Or try lower vyvanse dosage?
ADHD26
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
individuals diagnosed with ADHDA D H D Patients Undergoing Titration
Adults newly prescribed or adjusting stimulant medications who struggle to track side effects, blood pressure, and cognitive impacts systematically between doctor visits.
Context
Find an effective ADHD medication and dosage that improves focus and mental quietness without intolerable side effects.
Taking unguided medication breaks after experiencing adverse side effects.
Self-evaluating and contemplating dosage adjustments or switching between different stimulant medications.
Current Workarounds
taking unguided medication breaks after experiencing adverse side effects
self-evaluating and contemplating dosage changes without structured data
relying on memory or unstructured notes during psychiatric follow-ups
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Standard stimulant medication dosages and increments (like Concerta and Vyvanse) frequently cause severe physical and psychological side effects instead of providing smooth symptom management.
OPPORTUNITY & VALUE
Why Now
Repeated complaints across multiple stimulant medications regarding physical and psychological overstimulation, anxiety, and high blood pressure during titration phases.
Value Proposition
Purpose-built specifically for stimulant titration side effects and dosage tracking, rather than generic habit or mood logging.
Product Direction
A dedicated mobile tracking app specifically designed for ADHD stimulant titration that logs daily metrics (blood pressure, heart rate, focus quality, side effects like paranoia or derealisation), provides visual trend lines, and generates clinician-ready summaries to streamline dosage adjustments.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$6.99/moIndividual patient tier · advanced doctor report export
Model
Freemium SaaS
WILLINGNESS TO PAY
Patients experiencing severe side effects and frequent medication switches spend considerable money on wasted prescriptions and unproductive doctor visits; a low monthly fee for clarity and faster dosage optimization represents high personal ROI.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Track stimulant side effects and find your optimal ADHD dosage with data-driven clarity.”
A dedicated mobile tracking app specifically designed for ADHD stimulant titration that logs daily metrics (blood pressure, heart rate, focus quality, side effects like paranoia or derealisation), provides visual trend lines, and generates clinician-ready summaries to streamline dosage adjustments.
Core Features
Daily check-in for physical side effects (blood pressure, heart rate, overstimulation, anxiety) and cognitive focus
Structured medication and dosage change history log
Exportable PDF summary for psychiatric follow-up appointments
Weekly Roadmap
1
W1-W2
Core data schema and daily check-in flow built for side effects and dosages.
- •Design mobile-friendly daily check-in UI for stimulants
- •Build secure local storage and user authentication
- •Implement blood pressure, heart rate, and side effect metrics logging
2
W3-W4
Trend visualization and PDF clinician report generation operational.
- •Build charts correlating dosage levels with side effect frequency
- •Develop exportable PDF report formatted for psychiatric visits
- •Add medication switch and titration history timeline
3
W5
In-app billing and closed beta with 15 ADHD patients.
- •Integrate mobile subscription billing via App Store/Google Play
- •Recruit 15 beta testers from ADHD online communities undergoing titration
- •Gather feedback on friction points during side effect episodes
4
W6
Public store submission and community launch.
- •Finalize app store compliance and privacy policy reviews
- •Publish launch announcement in targeted ADHD communities
- •Monitor initial user acquisition and crash reports
Launch Strategy
Community-led growth targeting ADHD support groups, subreddits (r/ADHD, r/ADHD_anxiety), and partnering with independent psychiatric nurse practitioners and ADHD clinics.
RISKS & ASSUMPTIONS
Top Risks
Medical advice liability
Users might misinterpret app insights as medical recommendations for dosage changes without consulting their physician.
High churn post-titration
Once a patient finds the right medication and stable dosage, daily tracking utility drops significantly, leading to cancellations.
Data fatigue during severe side effects
Users experiencing intense overstimulation, anxiety, or brain fog may abandon logging apps when they need them most.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 9/10 against 3 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
Why this matters for SaaS founders
It sits at the intersection of "healthcare", "mental-health", "mobile-app", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "TitrateTrack: Structured Symptom & Dosages Log for ADHD Medication Titration" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for healthcare?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.